Monday, March 24, 2025
Home Tags Fbio

Tag: fbio

2020 Watch List

There’s Simply No Loyalty Anymore.

Editor / Curator -
Roland Rick Perry, Biotech Stock Review, Frontier Bio
Biotech News

And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Editor / Curator -
Biotech News

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double...

Editor / Curator -
biotech stock review ATXI
Biotech News

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted...

Editor / Curator -
Biotech News

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Editor / Curator -
Immunomedics, Biotech Stock Review
All News

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in...

Editor / Curator -
All News

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
Lindsay Rosenwald, Biotech Stock Review
Biotech News

Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!

Editor / Curator -
Biotech News

Cougar Biotechnology. A $500,000 Investment Acquired for $1 Billion.

Editor / Curator -
12Page 1 of 2

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.